Featured Article

PACCAR Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD May 16, 2025

PACCAR, a multinational truck, parts, and financing company, had a negative 2024. Examining PACCAR’s Truck, Parts, and Other business specifically, revenue fell 5% to $31 billion and earnings before interest and taxes fell 17% to $4.5 billion over the last year. (This article excludes PACCAR’s financial services business and makes no comments regarding how pricing should be managed in that line of business.) A review of PACCAR’s 28 January 2025 earnings call…

Read More

In This Issue

unsplash default post photo-350px

Bombardier CSeries: How will Boeing/Airbus Duopoly Respond?

By Curry W. Hilton February 4, 2013

The much-anticipated Bombardier CSeries commercial airplane line provides a uniquely positioned offering, boasting 20% fewer CO2 emissions, 20% fuel savings, and 15%…

Read More
unsplash default post photo-350px

Apple Takes a Beating — What Did You Expect?

By Tim J. Smith, PhD February 4, 2013

Apple has had a beating both in the market and the press lately. Despite record quarterly profit, they lost their number-one stock spot to Exxon Mobil. By some prognostications, Samsung is rising in the smartphone market, and Huawei is taking a stronger foothold on the price-sensitive emerging-market field, while Apple is stumbling. Well, for those who failed to sell Apple at above $700 prices and now see it below $450, what did you expect?

Read More
unsplash default post photo-350px

Is Your Board of Directors Considering the Right CEO Strategic Business Priorities?

By David Dalka February 4, 2013

Business guru Harvey Mackay stated, “The Japanese have a very simple way of describing the typical American marketing plan: READY? FIRE! AIM.” Sadly little has changed in American business. This is a major reason why the American economy is in constant crisis, and obsolete marketing departments built on late twentieth-century dogma now resemble the spending habits of Communist central planning: disconnected from reality, economically inefficient and lacking accountability to the right things.

Read More
unsplash default post photo-350px

An Intriguing Possibility – Legalize All Drugs

By James T. Berger February 4, 2013

Two academic giants, Nobel Prize Winner (in economics) Gary Becker of the University of Chicago and Kevin W. Murphy another U. of Chicago economics professor, argue that we have lost the war on drugs. So is it time to legalize and tax this industry?

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX